Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-01 to 2023-03-22
Current total value of award: $4602.84
Description: 4560271659!OMIDRIA 1-0.3% VIAL 4ML